EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS177-14701 
Organism
Homo sapiens 
Tissue/cell
SK-N-SH_RA 
Coordinate
chr3:4909830-4910820 
TF binding sites/motifs
Number: 4             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF16MA0741.1chr3:4910267-4910278GCCCCGCCCCC+6.02
KLF5MA0599.1chr3:4910267-4910277GCCCCGCCCC+6.02
NRF1MA0506.1chr3:4910169-4910180GCGCCTGCGCG+6.14
SP4MA0685.1chr3:4910264-4910281ATCGCCCCGCCCCCTCC+6
Number of super-enhancer constituents: 4             
IDCoordinateTissue/cell
SE_18602chr3:4908063-4912293CD4p_CD25-_Il17-_PMAstim_Th
SE_19590chr3:4908204-4911214CD4p_CD25-_Il17p_PMAstim_Th17
SE_20241chr3:4907902-4911210CD56
SE_49889chr3:4905767-4910143RPMI-8402
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr349099174910799
Number: 1             
IDChromosomeStartEnd
GH03I004866chr349078454911822
Enhancer Sequence
GCCAAGTCAC TTTCCAAAGG TCACAGCTGG TAGCAGGCCG AGGAGGGCCT CCAGGCCTGG 60
TGCTTGCGAC CCTCAACGAC CATCTGTAAT AATGCCCAGA GCCTCTGCCA GGATTCCCCA 120
GCCCTATGTT CCCGCGGCCT TTGAGGGGAA AGGGCCAGGG CCTAGACGTT CCCCTCCCGC 180
GTGGTTTTCC CGTCAGCAGC TTTCGTCTGC AAGGGAAAGC GGCGGCCCCA CCCGCAGACA 240
GCTGCGAGGC ACCGCGCCAA GCGTATGCGC CTGTTCCCAG GCACTCCCTC CTCCGCCTTC 300
ACCCTTTTGC CACCTCCGCC CTCCACCCAG CCCCGCCGTG CGCCTGCGCG CCCCGGCCCG 360
TGGGCCAGCG GGCAGTCTAC TCACGTGGGC CTCCGCATGG CCCAGCGCCG CCAAGGGCAA 420
GGCGGAGCCT CGCGATCGCC CCGCCCCCTC CGTGCCCCGC CTCCTGTAGG GAGCGCGGGA 480
CCCTCGGCTG GCGCGGGCAC TTCCCAGCCC AGCCCGGGGC GCCGGCTTCG CCGCGTGCGC 540
GTGCGCATGG TGGGGTTTGG CTGGCTGCGG GATGCGGTCG AGGCCGCCGA GGCCGCAAAC 600
TCCAGTGGGA AGGCGGCGTG CCGCGGCCGG CTTCGGTGGA GGAGGGGGCG TTTCCCCGGA 660
AAAGGAAGGA AGTGGGTGTC ACGGGCCTCA ATACGGCCCC TTTGACGTCT TGAGTGGGAA 720
ATCACAAGAT ACTGCTCCAG ATTTTCCCAT TTTATGGCTA AATCCAAATG ACTCGGACCC 780
CCTGCCCCAT CACATCAGGA ACTTCAGCAG TTCCTTCCAC CAAAGCTCAA CTATTGCTGC 840
AAGCGCTTTG GTAATCACGA GCATTATCTA TGAAGCTACT GCTGTGGTCA GGGCCCCAGT 900
CGTCCTGCTG AGTAGCAGAC TTTGAAAGAC GGTGTCCAAG GCCACCCTGC TGGTCAGTGA 960
CCTGCTCTAG AGGCTAAGCC AGGGCATGCT 990